Johnson and Johnson - JNJ Market Value

Johnson & Johnson (JNJ) maintains its leadership in the healthcare sector, leveraging a broad portfolio of pharmaceuticals and equipment to neutralize pricing pressure. The company is advancing high-tech pharmaceuticals and robotics through the acquisition of R&D projects, with a market capitalization of 674.71. Historical price action confirms the resilience of this ecosystem, where the synergy between patents and hospital supplies creates significant barriers to customer churn.

J&J - JNJ Market Value (period 07/04/2022 - 11/11/2026)

Johnson & Johnson Co. (JNJ) - metric breakdowns and financial figures

- market price and analyst price targets:

Price Chart J&J|JNJ - Broker Consensus Forecast

- issuer market value details:

Market Value Johnson & Johnson Co.|JNJ - Aggregate Business Value

- book value of equity indicators:

Book Value per Share Johnson & Johnson|JNJ - Accounting Value of Company|Market Value to Book Value Ratio jnj.com|JNJ - Company Assets

- debt obligations and liquidity statistics:

- financial results and valuation multiples details:

JNJ - Annual Net Income|Expected Profit Johnson & Johnson|JNJ - Market Price to Net Income Ratio|Future Price to Earnings Johnson & Johnson Inc.|JNJ - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Johnson & Johnson Co.|JNJ - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Johnson & Johnson|JNJ - Earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months jnj.com|JNJ - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Johnson & Johnson

Fundamental company valuation:J&J JNJ

Original product of Johnson & Johnson Co.

Market capitalization is calculated as the product of the current share price and the total number of outstanding shares, determining the aggregate value of the business in the eyes of investors. For Johnson & Johnson (JNJ), this metric reflects market recognition of its strategy to integrate medical startups and digital innovations, which clearly confirms the issuer's long-term capitalization level.

Analysis of competing companies